Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants.
Geller F, Wu X, Lammi V, Abner E, Valliere JT, Nastou K, Rasmussen M, Andersson NW, Quinn L, Aagaard B, Banasik K, Bliddal S, Boding L, Brunak S, Brons N, Bybjerg-Grauholm J, Christoffersen LAN, Didriksen M, Dinh KM, Erikstrup C, Feldt-Rasmussen U, Groenbaek K, Kaspersen KA, Mikkelsen C, Nielsen CH, Nielsen HS, Nielsen SD, Nissen J, Sequeros CB, Tommerup N, Ullum H, Spiliopoulos L, Bager P, Hviid A, Sorensen E, Pedersen OB, Lane JM, Lassauniere R, Ollila HM, Ostrowski SR, Feenstra B.
Geller F, et al. Among authors: wu x.
medRxiv [Preprint]. 2024 Nov 22:2024.11.21.24317689. doi: 10.1101/2024.11.21.24317689.
medRxiv. 2024.
PMID: 39606378
Free PMC article.
Preprint.